First Header Logo Second Header Logo

Connection

Roy Strowd to Immunologic Factors

Back to Details
This is a "connection" page, showing publications Roy Strowd has written about Immunologic Factors.
Roy Strowd
Connection Strength
0.160
Immunologic Factors
  1. Bhargava P, Wicken C, Smith MD, Strowd RE, Cortese I, Reich DS, Calabresi PA, Mowry EM. Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement. Mult Scler Relat Disord. 2019 May; 30:136-140.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.